Lyme Disease

Vaccine Candidate Data Reported

Published in Vaccine Weekly, July 8th, 1996

MedImmune, Inc., Gaithersburg, Maryland, reported data on lyme borreliosis at the Seventh International Congress on Lyme Borreliosis, held June 16-21, 1996, in San Francisco, California, showing that animals are protected from infection caused by the Lyme disease-causing bacterium Borrelia burgdorferi by antibodies to a newly identified protein.

The protein, called decorin binding protein (DBP), was recently discovered in B. burgdorferi by Texas A&M, Houston, scientists and licensed exclusively to MedImmune. Data reported at the meeting suggested that as a Lyme disease vaccine candidate, DBP may provide advantages over outer surface protein A (OspA),...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1996-07-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry